ArticleOccupational and environmental medicine2017
The economic burden of lung cancer and mesothelioma due to occupational and para-occupational asbestos exposure.
Article in Occupational and environmental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Counting the social, psychological, and economic costs of COVID-19 for cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Pooled it
- The psychosocial cost burden of cancer: A systematic literature review.Psycho-oncology · 2020Pooled it
- Economic Impact of Asbestos in Colombia: Estimation of the Direct and Societal Costs of Lung Cancer and Mesothelioma in 2022.International journal of environmental research and public health · 2026Article
- Pleural mesothelioma.Nature reviews. Disease primers · 2025Review
- Global burden of tracheal, bronchus, and lung cancer attributable to occupational carcinogens in 204 countries and territories, from 1990 to 2019: results from the global burden of disease study 2019.Annals of medicine · 2023Article
- Longitudinal Assessment of Labor Market Earnings Among Patients Diagnosed With Cancer in Canada.JAMA network open · 2022Article
- Social return on investment economic evaluation of supportive care for lung cancer patients in acute care settings in Australia.BMC health services research · 2022Article
- Time to Break the "Lock-In" Impediments to Chemicals Management.Environmental science & technology · 2022Article
- Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland.Thoracic cancer · 2021Article
- Hospitalisation costs of malignant mesothelioma: results from the Italian hospital discharge registry (2001-2018).BMJ open · 2021Article
- Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040.Cancers · 2021Article
- Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma.BMC pulmonary medicine · 2021Review
- Economic burden of work injuries and diseases: a framework and application in five European Union countries.BMC public health · 2021Article
- Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma.Frontiers in oncology · 2021Article
- The Economic Burden of Cancers Attributable to Infection in the Republic of Korea: A Prevalence-Based Study.International journal of environmental research and public health · 2020Article
- Eliminating Take-Home Exposures: Recognizing the Role of Occupational Health and Safety in Broader Community Health.Annals of work exposures and health · 2020Review
- A probabilistic approach for economic evaluation of occupational health and safety interventions: a case study of silica exposure reduction interventions in the construction sector.BMC public health · 2020Article
- One-Hour Pilot Training to Prevent Workers From Taking Home Workplace Contaminants.New solutions : a journal of environmental and occupational health policy : NS · 2020Article
- Asbestos-Related Disorders in Germany: Background, Politics, Incidence, Diagnostics and Compensation.International journal of environmental research and public health · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo estimate the economic burden of lung cancer and mesothelioma due to occupational and para-occupational asbestos exposure in Canada.
methodsWe estimate the lifetime cost of newly diagnosed lung cancer and mesothelioma cases associated with occupational and para-occupational asbestos exposure for calendar year 2011 based on the societal perspective. The key cost components considered are healthcare costs, productivity and output costs, and quality of life costs.
resultsThere were 427 cases of newly diagnosed mesothelioma cases and 1904 lung cancer cases attributable to asbestos exposure in 2011 for a total of 2331 cases. Our estimate of the economic burden is $C831 million in direct and indirect costs for newly identified cases of mesothelioma and lung cancer and $C1.5 billion in quality of life costs based on a value of $C100 000 per quality-adjusted life year. This amounts to $C356 429 and $C652 369 per case, respectively.
conclusionsThe economic burden of lung cancer and mesothelioma associated with occupational and para-occupational asbestos exposure is substantial. The estimate identified is for 2331 newly diagnosed, occupational and para-occupational exposure cases in 2011, so it is only a portion of the burden of existing cases in that year. Our findings provide important information for policy decision makers for priority setting, in particular the merits of banning the mining of asbestos and use of products containing asbestos in countries where they are still allowed and also the merits of asbestos removal in older buildings with asbestos insulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.